Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Rigel Pharmaceuticals, Inc. (Rigel or 'the company') is a biotechnology company that discovers, develops and provides novel small molecule drugs. Its products are used in immunology, inflammatory, autoimmune, oncology, hematology and immuno-oncology related therapeutic areas. Its products include IgAN, autoimmune hemolytic anemia, and immune thrombocytopenic. The company conducts various clinical trials and receives approval from the US Food and Drug Administration (FDA) before implementing on various patients. Rigel Pharmaceuticals collaborates with various pharmaceutical companies for developing therapeutic drugs. It markets its products through partnerships in various geographical regions including the North America, Europe, and Asia-Pacific. The company is headquartered in South San Francisco, California, the US.Scope
- Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Rigel Pharmaceuticals, Inc.: Company Overview
- Rigel Pharmaceuticals, Inc.: Overview and Key Facts
- Rigel Pharmaceuticals, Inc.: Overview
- Rigel Pharmaceuticals, Inc.: Key Facts
- Rigel Pharmaceuticals, Inc.: Key Employees
- Rigel Pharmaceuticals, Inc.: Key Employee Biographies
- Rigel Pharmaceuticals, Inc.: Major Products and Services
- Rigel Pharmaceuticals, Inc.: Management Statement
- Rigel Pharmaceuticals, Inc.: Key Competitors
- Rigel Pharmaceuticals, Inc.: Company Analysis
- Rigel Pharmaceuticals, Inc.: Business Description
- Rigel Pharmaceuticals, Inc.: SWOT Analysis
- Rigel Pharmaceuticals, Inc.: SWOT Overview
- Rigel Pharmaceuticals, Inc.: Strengths
- Rigel Pharmaceuticals, Inc.: Weaknesses
- Rigel Pharmaceuticals, Inc.: Opportunities
- Rigel Pharmaceuticals, Inc.: Threats
- Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity
- Rigel Pharmaceuticals, Inc.: Financial Deals Overview
- Rigel Pharmaceuticals, Inc.: Targets and Partners
- Rigel Pharmaceuticals, Inc.: Top Deals 2020 - 2024YTD*
- Rigel Pharmaceuticals, Inc.: Partnership
- Rigel Pharmaceuticals, Inc.: Recent Developments
- Rigel Pharmaceuticals, Inc.: News and Events Summary
- Rigel Pharmaceuticals, Inc.: Financial Deals
- Rigel Pharmaceuticals, Inc.: Financial Performance
- Rigel Pharmaceuticals, Inc.: Market Developments
- Rigel Pharmaceuticals, Inc.: Research & Development
- Rigel Pharmaceuticals, Inc.: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: Rigel Pharmaceuticals, Inc.: Key Facts
- Table 2: Rigel Pharmaceuticals, Inc.: Key Employees
- Table 3: Rigel Pharmaceuticals, Inc.: Key Competitors
- Table 4: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 5: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 6: Rigel Pharmaceuticals, Inc.: Targets and Partners
- Table 7: Rigel Pharmaceuticals, Inc.: Top Deals 2020 - 2024YTD*
- Table 8: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 9: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 10: Rigel Pharmaceuticals, Inc.: News and Events Summary
- Table 11: Rigel Pharmaceuticals, Inc.: Financial Deals
- Table 12: Rigel Pharmaceuticals, Inc.: Financial Performance
- Table 13: Rigel Pharmaceuticals, Inc.: Market Developments
- Table 14: Rigel Pharmaceuticals, Inc.: Research & Development
- Table 15: Rigel Pharmaceuticals, Inc.: Strategy and Operations
- Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 3: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 4: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
